Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Aquivia Health vs Maven Clinic

Aquivia Health
Graded #81

Higher grade

vs+14.200000000000003
Maven Clinic
Graded #383

Lower grade

The verdict

Aquivia Health takes it — 72.2/100 to 58/100.

Aquivia Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Aquivia Health is a clinician-led, self-pay telehealth platform offering compounded GLP-1 therapy with the option to step up to branded Ozempic or Zepbound — an unusual side-by-side most compounded…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAquivia Health +41
86
45
Dose & formulationAquivia Health +32
85
53
Clinical oversightMaven Clinic +13
64
77
Labs & monitoringEven
53
53
FulfillmentAquivia Health +1
71
70
Contract termsEven
55
55
Aquivia Health · left barMaven Clinic · right bar

The numbers

MetricAquivia HealthMaven Clinic
WeighScore72.2/10058/100
GradeCC
Scorecard rank#81#383
Semaglutide$149/moNot disclosed
Tirzepatide$179/moNot disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyInjection only
Aquivia Health

Graded #81 · C

Strengths

  • Clinical care provided by Open Loop Healthcare Partners, PC — a reused, verified MSO network
  • Named leadership: Steven Bishop MD (CMO), Phillip Gray PharmD (Chief Pharmacist), Tom Foster (President)
  • Itemized public pricing: compounded semaglutide $149/mo, tirzepatide $179/mo, Ozempic $1,299, Zepbound $1,399
  • Both compounded and branded GLP-1s offered side by side — unusual for a compounded provider
  • Self-pay model with no insurance required and no separate consultation fee

Where it loses points

  • No public list of states served — you must complete intake to learn if your state qualifies
  • No named 503A compounding pharmacy partner, limiting licensure verification
  • No LegitScript, PCAB, or BBB trust badges visible
  • Brand confusion: site schema names 'CatalystMD' while the customer-facing brand is Aquivia Health
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
Maven Clinic

Graded #383 · C

Strengths

  • Dedicated GLP-1 Care program with brand-name (FDA-approved) GLP-1 prescriptions
  • On-demand visits with metabolic and hormone-health specialists, plus nutrition and strength support
  • Integrated with broader women's, hormone, and family health care
  • LegitScript-verified; trusted by 2,300+ employers
  • Available as both an employer health benefit and a consumer self-pay option

Where it loses points

  • Pricing is not published on the public site
  • Primarily distributed through employers and health plans — direct access can depend on your plan
  • US state availability for GLP-1 is not specified publicly
  • Brand-name only — no lower-cost compounded option

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard